OBJECTIVE: Evaluation of the long-term benefits of combined pharmacological and psychotherapeutic depression treatment and the differential impact of early childhood trauma. METHOD: A randomized trial was conducted in 124 in-patients with a diagnosis of major depressive disorder comparing 5 weeks ofinterpersonal psychotherapy plus pharmacotherapy (IPT) with medication plus clinical management (CM). The study included a prospective, naturalistic follow-up 3, 12 and 75 months after in-patient treatment. The Hamilton Rating Scale for Depression (HRSD) served as the primary outcome measure. RESULTS: Patients in both treatments reduced their depressive symptoms between baseline and 5-year follow-up significantly with a faster decrease early in the follow-up phase. The time rate of change and acceleration on the HRSD was higher for patients in the combination therapy group. The contrast between the conditions at year 5 was non-significant. However, 28% of the IPT patients showed a sustained remission compared with 11% of the CM patients (P = 0.032). Early adversity was found to be a moderator of the relationship between treatment and outcome. CONCLUSION: In the long-term, a combination of psycho- and pharmacotherapy was superior in terms of sustained remission rates to standard psychiatric treatment. Early trauma should be assessed routinely in depressed patients.
RCT Entities:
OBJECTIVE: Evaluation of the long-term benefits of combined pharmacological and psychotherapeutic depression treatment and the differential impact of early childhood trauma. METHOD: A randomized trial was conducted in 124 in-patients with a diagnosis of major depressive disorder comparing 5 weeks of interpersonal psychotherapy plus pharmacotherapy (IPT) with medication plus clinical management (CM). The study included a prospective, naturalistic follow-up 3, 12 and 75 months after in-patient treatment. The Hamilton Rating Scale for Depression (HRSD) served as the primary outcome measure. RESULTS:Patients in both treatments reduced their depressive symptoms between baseline and 5-year follow-up significantly with a faster decrease early in the follow-up phase. The time rate of change and acceleration on the HRSD was higher for patients in the combination therapy group. The contrast between the conditions at year 5 was non-significant. However, 28% of the IPTpatients showed a sustained remission compared with 11% of the CMpatients (P = 0.032). Early adversity was found to be a moderator of the relationship between treatment and outcome. CONCLUSION: In the long-term, a combination of psycho- and pharmacotherapy was superior in terms of sustained remission rates to standard psychiatric treatment. Early trauma should be assessed routinely in depressedpatients.
Authors: Uraina S Clark; Lawrence H Sweet; Susan Morgello; Noah S Philip; Ronald A Cohen Journal: Brain Imaging Behav Date: 2017-06 Impact factor: 3.978
Authors: Shannon M Peters; Kendra Quincy Knauf; Christina M Derbidge; Ryan Kimmel; Steven Vannoy Journal: Gen Hosp Psychiatry Date: 2015-06-10 Impact factor: 3.238
Authors: Mark J Niciu; Chadi G Abdallah; Lisa R Fenton; Madonna K Fasula; Anne Black; George M Anderson; Gerard Sanacora Journal: J Affect Disord Date: 2015-08-19 Impact factor: 4.839
Authors: Janice A Blalock; Jennifer A Minnix; Amanda R Mathew; David W Wetter; James P McCullough; Paul M Cinciripini Journal: J Consult Clin Psychol Date: 2013-06-10
Authors: Lynnette A Averill; Chadi G Abdallah; Lisa R Fenton; Madonna K Fasula; Lihong Jiang; Douglas L Rothman; Graeme F Mason; Gerard Sanacora Journal: Eur Neuropsychopharmacol Date: 2020-05-15 Impact factor: 4.600
Authors: Ágnes Péterfalvi; Nándor Németh; Róbert Herczeg; Tamás Tényi; Attila Miseta; Boldizsár Czéh; Maria Simon Journal: Front Psychol Date: 2019-08-06